
Naturn Medical Devices Participated In The 37th European Congress of Pathology (ECP 2025) at Vienna, Austria
With the theme "ECP Vienna – Where Tradition Meets the Future", this year's congress brought together over 5,700 Pathology experts, clinicians and researchers from more than 100 countries around the world.

Hemogenomics Pvt. Ltd. visits Naturn Medical Devices
On February 24th, 2025, Mr. Sumit Bagaria, the Managing Director & CEO of Hemogenomics Pvt. Ltd., paid a visit to Naturn Medical Devices. Hemogenomics, a pioneer in blood and cancer screening, and Naturn, leading in pathological devices, engaged in a productive exchange.

Naturn Medical Devices Showcases Tissue Microarrayer at 2024 Clinical Data and Sample Repository Committee Annual Conference, China Research Hospital Association
Naturn Medical Devices Co., Ltd. proudly exhibited its revolutionary Auto12A Tissue Microarrayer at 2024 Clinical Data and Sample Repository Committee Annual Conference, China Research Hospital Association, held in Xiong'an New Area of Hebei Province during 19th~22nd September 2024.







